Posts by: Joana Carvalho

Joana Carvalho

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

February 18, 2021February 18, 2021

Yuflyma, Biosimilar of Humira, Approved for Use in Europe

News

The European Commission (EC) has approved Yuflyma (CT-P17), an adalimumab biosimilar, to treat multiple chronic inflammatory diseases, including juvenile idiopathic arthritis. Similar to generics, biosimilars are products that have identical ... Read more

February 11, 2021February 11, 2021

Genetic Signature May Identify sJIA Children Who Respond to Ilaris

News

A specific genetic signature can help in identifying children with systemic onset juvenile arthritis (sJIA) who are most likely to respond well to Ilaris (canakinumab), a study suggests. Children with ... Read more

February 18, 2020February 18, 2020

Investigators Create New Tool to Evaluate the Impact of JIA on Caregivers

News

Investigators have created a new questionnaire to assess the psychosocial and economic impact of juvenile idiopathic arthritis (JIA) on caregivers of children with the disease. The new tool was described in the ... Read more

January 31, 2020January 31, 2020

Liver, Spleen, Lymph Nodes Can Help Distinguish Acute Lymphoblastic Leukemia from JIA, Study Says

News

An enlarged liver and spleen and swollen lymph nodes are telltale signs that can help physicians distinguish acute lymphoblastic leukemia (ALL) from juvenile idiopathic arthritis (JIA) in children with a ... Read more

December 17, 2019December 17, 2019

Slightly Higher Cancer Risk in JIA Not Linked to Use of Biological Therapies, Study Says

News

Children and adolescents with juvenile idiopathic arthritis (JIA) have a slightly higher risk of developing lymphoma and multiple myeloma compared to the general population, a study says. However, this higher ... Read more

October 8, 2019December 11, 2019

Children with Systemic JIA Should Be Monitored Closely for Signs of Lung Disease, Study Urges

News

Parents and physicians should be on the lookout for subtle signs of lung disease in children with systemic juvenile idiopathic arthritis, a study has found. The study results, “Emergent high ... Read more

October 4, 2019October 4, 2019

Differences Seen in Gut Bacteria of Children with Systemic-Onset JIA, Study Says

News

Children with systemic-onset juvenile idiopathic arthritis have significant differences in the composition of gut bacteria compared to healthy children, which may be partially resolved by treatments that stop disease activity, ... Read more

September 20, 2019September 20, 2019

Arava May Be Viable Alternative for Methotrexate-intolerant JIA Patients, Study Says

News

Arava (leflunomide) may be a viable alternative for reducing disease activity for patients with juvenile idiopathic arthritis who are intolerant to methotrexate, a study finds. The results, “Leflunomide treatment in ... Read more

September 17, 2019September 17, 2019

Pain Sensitivity in JIA Patients May Be Linked to Their History of Joint Inflammation, Study Says

News

Human patients and rat models of juvenile idiopathic arthritis have unique thresholds of pain sensitivity, which is most likely related to their history of disease activity and joint inflammation rather ... Read more

September 6, 2019September 6, 2019

Physicians Should Be on Lookout for MAS Indicators in Children With sJIA, Study Says

News

Variations in the levels of two proteins — ferritin and fibrinogen — at the time of a systemic juvenile idiopathic arthritis diagnosis may be early warning signs of macrophage activation ... Read more